Cashu Logo
HomeWatchlistNewsSignalsPicks
DJI
-1.23%
SPX
-1.60%
IXIC
-2.24%
FTSE
-0.70%
N225
-0.66%
AXJO
-0.92%
Cashu Logo
Log In
HomeWatchlistNewsSignalsPicks
Stocks
0.00 (0.00%)
0.000
USD
At close at --,----
Cashu Logo Alt
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

  • About Us
  • Careers
  • Blog
  • News

Help & Support

  • Help Center
  • Contact Us
  • Pro Support

Legal

  • Privacy Policy
  • Terms of Use
InstagramYouTube

© 2024 Cashu PTY LTD.

Join our newsletter to keep up to date with us!

Overview

Loading chart...

Key Stats

Market Cap
318.82M
Dividend Yield
0.00%
P/E Ratio
-1.24
EPS
-2.73
Revenue
-
Avg. Volume
2.44M

About

What does RCKT do?
Rocket Pharmaceuticals, based in Cranbury, New Jersey, develops gene therapies for rare pediatric diseases and employs 268 people. The company targets conditions like Fanconi Anemia and Leukocyte Adhesion Deficiency-I.
Sector
💻 Health Care
IPO
CEO
Employees
299 employees
Headquarters
New York, USA
Website
http://www.rocketpharma.com

Recently from Cashu

publisher logo
Cashu

Rocket Pharmaceuticals Restructures for Enhanced Efficiency and Focus on Gene Therapy Innovations

6 days ago
publisher logo
Cashu

Rocket Pharmaceuticals (RCKT) Restructures to Boost Gene Therapy Development and Innovation

8 days ago
publisher logo
Cashu

Rocket Pharmaceuticals Advances RP-A501 Gene Therapy for Danon Disease Treatment

2 months ago
Stocks
Health Care
rckt
Rocket Pharmaceuticals
NASDAQ: RCKT
-0.07 (-2.30%)
2.98
USD
At close at Aug 01, 20:42 UTC
Summary
News
Signals
Benchmarks
Financials